| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $359.5M | — | +32.2% |
| Gross Profit | $85.8M | — | +34.7% |
| R&D Expense | $2.4M | — | -5.4% |
| SG&A Expense | $9.8M | — | -31.9% |
| Operating Income | $42.5M | — | +50.0% |
| Pre-tax Income | $45.9M | — | +41.3% |
| Income Tax | $7.8M | — | +45.4% |
| Net Income | $38.1M | — | +40.4% |
| EPS (Basic) | $1.04 | — | +52.9% |
| EPS (Diluted) | $1.04 | — | +52.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $330.3M | -13.0% | +31.2% |
| Short-term Investments | $32.9M | -9.3% | -6.2% |
| Accounts Receivable | $83.5M | +26.6% | +24.6% |
| Inventory | $240.3M | +27.6% | +17.3% |
| Current Assets | $708.9M | +2.6% | +22.4% |
| Total Assets | $1.23B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.7M | — | -330.4% |
| Capital Expenditures | $4.5M | — | +86.6% |
| Investing Cash Flow | -$14.8M | — | -420.2% |
| Financing Cash Flow | -$12.4M | — | +45.5% |
| Free Cash Flow | -$26.2M | — | -472.3% |
| +12.8% |
| Current Liabilities | $342.9M | +0.2% | +17.5% |
| Total Liabilities | $719.9M | +0.5% | +6.2% |
| Stockholders' Equity | $510.3M | +5.0% | +23.6% |